Adamax research: overview and resources

What is Adamax?

Adamax is a research peptide described by Klow Labs as a modified analogue of Semax, the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro built on the ACTH(4–7) fragment. Published research on Adamax itself is very limited, and findings on Semax should not be assumed to carry over to a modified analogue. For that reason this site will state Adamax's identity only from what the laboratory certificate establishes, and will not repeat unverified structural claims.

Adamax Labs lists Adamax in 10 mg vials through Klow.bio. The current lot, KB-88324, was tested by Freedom Diagnostics, which reports HPLC-UV purity 99.40%, identity confirmed by LC-MS at 984 Da, and 13.75 mg measured in a 10 mg vial. The full certificate and its laboratory references are listed on the lot page.

Adamax is a product name. The exact structure is not published on the product page, so this site gives no formula. The laboratory certificate reports the LC-MS identity result as 984 Da.

What is Adamax research material?

Adamax research material is Adamax supplied for laboratory research in lyophilized powder form, sold by lot. Each lot's identity, purity and net content are documented by an independent laboratory in a published certificate of analysis.

How is Adamax characterized?

Three questions are answered for every lot, each by a different method:

• Is it the right compound? LC-MS separates the sample and measures the mass of the main component, confirming it has the molecular weight expected for the compound.
• How much of the sample is that compound? HPLC-UV reports the main peak's share of detected peak area. Current lots: 99.40%.
• How much peptide is in the vial? Net content is measured directly.

Endotoxin (LAL) and microbial DNA (PCR) results are added where those tests are run.

What has not been established

A certificate of analysis describes the specific sample tested on its test date. It does not establish stability afterward, sequence order beyond what mass confirmation shows, results for other lots, or suitability for any particular purpose.

Research references

Published sources

1. PubChem: Semax. National Library of Medicine, NIH. pubchem.ncbi.nlm.nih.gov/compound/9811102
2. Wilm M. Principles of electrospray ionization. Mol Cell Proteomics. 2011. PMC3134074. pmc.ncbi.nlm.nih.gov/articles/PMC3134074
3. U.S. FDA. Q2(R2) Validation of Analytical Procedures. 2024. fda.gov
4. U.S. FDA. Pyrogen and Endotoxins Testing: Questions and Answers. Revised 2026. fda.gov

Adamax Labs analytical documentation

• Lot KB-88324: 10 mg, 99.40% purity, reported Nov 1, 2026
• Adamax testing records (all tests, all lots; CSV available)

Editorial scope

Adamax Labs research content covers molecular characteristics, peptide structure, analytical chemistry, purity and identity testing, certificates of analysis, lot documentation and laboratory storage and handling.

It does not cover dosing, administration instructions, protocols, personal use or medical advice.

Latest updates

• Nov 15, 2026: Adamax.bio launched
• Nov 15, 2026: Adamax specifications page published
• Nov 15, 2026: Adamax testing records published
• Nov 1, 2026: Adamax 10 mg, lot KB-88324

All research updates